Splanchnic Venous Pressure–Volume Relation During Experimental Acute Ischemic Heart Failure
- 15 February 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 91 (4) , 1205-1212
- https://doi.org/10.1161/01.cir.91.4.1205
Abstract
Background Vasodilator drugs have variable effects on veins and arteries. However, direct measurements of their effects on the splanchnic veins, perhaps the most important volume reservoir, have not been reported. We assessed the effect of acute heart failure and the subsequent administration of hydralazine, enalaprilat, and nitroglycerin on the splanchnic venous pressure–volume relation in intact dogs. Methods and Results Experimental acute ischemic heart failure was induced in 19 splenectomized dogs by microsphere embolization of the left main coronary artery. Embolization was repeated until left ventricular end-diastolic pressure (LVEDP) reached 20 mm Hg and cardiac output decreased by 50%. The splanchnic vascular pressure–volume relation was determined by radionuclide plethysmography during the control stage, after acute heart failure had been established, and after administration of a vasodilator (hydralazine, enalaprilat, or nitroglycerin) at a dose sufficient to reduce mean aortic pressure by approximately 20%. Induction of acute heart failure was associated with a decrease in the splanchnic vascular volume from 100% to 86±2% and an increase in LVEDP from 6±1 to 21±1 mm Hg (P<.001). There was a parallel leftward shift of the splanchnic vascular pressure–volume curve. After the administration of hydralazine, enalaprilat, and nitroglycerin, the splanchnic vascular volumes increased from 86% to 88±3%, 96±3%, and 113±3%, respectively (P=NS, P<.01, and P<.001, respectively, versus heart failure). After drug administration, the LVEDPs were 18±2, 16±1, and 13±1 mm Hg (P=NS, P<.05, and P<.001, respectively, versus heart failure). Conclusions Acute heart failure was associated with a parallel leftward shift of the splanchnic venous pressure–volume relation (venoconstriction). Splanchnic (systemic) venoconstriction may in part explain the increased LVEDP during acute heart failure by displacement of blood to the central compartment. Subsequently administered enalaprilat and, to a greater degree, nitroglycerin produced splanchnic venodilation, thereby lowering LVEDP. Hydralazine had no significant effect on the splanchnic veins and only a modest effect on LVEDP. In this model, splanchnic capacitance changes appear to modulate change in left ventricular preload.Keywords
This publication has 35 references indexed in Scilit:
- Quantitative radionuclide assessment of total pulmonary vascular volume changesCanadian Journal of Physiology and Pharmacology, 1990
- Influence of splanchnic intravascular volume changes on cardiac output during muscarinic receptor stimulation in the anaesthetized dogActa Physiologica Scandinavica, 1990
- Alpha‐adrenergic regulation of splanchnic volume and cardiac output in the dogActa Physiologica Scandinavica, 1990
- Effect of acute angiotensin converting enzyme inhibition on left ventricular diastolic filling in patients with congestive heart failure: Relation to right ventricular volumeJournal of the American College of Cardiology, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Plasma concentrations of angiotensin II and aldosterone during acute left ventricular failure in the dog. Effect of converting enzyme inhibitionZeitschrift für Die Gesamte Experimentelle Medizin, 1986
- Comparative effects of vasodilator drugs on flow distribution and venous returnCanadian Journal of Physiology and Pharmacology, 1985
- Angiotensin-converting enzyme inhibition in congestive heart failure: The conceptThe American Journal of Cardiology, 1982
- Contributions of blood drainage from the liver, spleen and intestines to cardiac effects of aortic occlusion in the dogActa Physiologica Scandinavica, 1982
- Angiotensin inhibition in severe heart failure: Acute central and limb hemodynamic effects of captopril with observations on sustained oral therapyAmerican Heart Journal, 1981